Work time
full-time
Start date
As soon as possible
Employment period
limited
Application deadline
24.07.2026
Deployment location Charité
Campus Charité Mitte; Campus Virchow-Klinikum, Wedding; Campus Benjamin Franklin, Steglitz
Jobcode
7474
Salary group
E15
The Berlin Hub for Science and Society (BHS2) is an integral bridging programme of the newly established Cluster of Excellence ImmunoPreCept, which explores the health–disease bifurcation for cell-based molecular prevention and interceptive medicine. Within this Cluster, BHS2 strengthens structured, evidence-based connections between biomedical research and society.
The Berlin Hub for Science and Society (BHS2) is an integral bridging programme of the newly established Cluster of Excellence ImmunoPreCept, which explores the health–disease bifurcation for cell-based molecular prevention and interceptive medicine. Within this Cluster, BHS2 strengthens structured, evidence-based connections between biomedical research and society.
BHS2 conceptualises public engagement as both a field of research and a practice within biomedical research ecosystems and investigates how engagement shapes (i) research trajectories and innovation dynamics, (ii) researcher competencies and institutional research culture, (iii) societal attitudes, health-related behaviours and trust formation, and (iv) policy discourses and evidence-informed decision-making. Our work is explicitly practice-led and research-informed, generating empirical evidence from engagement practice while also translating research insights into institutional and sector-leading approaches.
The Cluster of Excellence ImmunoPreCept including BHS2 invite applications from outstanding individuals with a strong track record of impactful research and practice in science communication and public engagement with research (SCaPE). The successful candidate will establish and lead an independent junior research group with a clearly articulated, practice-inspired, and empirically grounded research agenda in public engagement research. The position offers a unique opportunity to shape an emerging field at the intersection of biomedical innovation, science–society relations, and institutional transformation within a dynamic interdisciplinary Cluster focused on precision prevention and interceptive medicine.
This role involves both intellectual leadership and operational responsibility. The group leader will manage and further develop BHS2 as a recognized centre of excellence in practice-led public engagement research, strengthening its visibility and influence across academic, policy, and practitioner communities. The position includes active supervision of doctoral researchers and contributions to graduate training within the Cluster.
You are engaged in academic work: Under Section 110(4), third sentence, the Berlin Higher Education Act provides for academic staff to be allocated a reasonable amount of time during working hours for their own further academic development.
The successful candidate will be expected to:
ImmunoPreCept advances a paradigm shift from treating manifest disease to intervening at the level of early molecular deviation, often before symptoms arise. This transformation raises profound societal, professional, ethical, and epistemic questions. The group leader is expected to develop a research program that critically examines the challenges associated with molecular prevention, pre-symptomatic intervention, and the integration of new biomedical avenues into healthcare systems, public discourse, and professional practice, such as:
Everyone is welcome at the Charité, regardless of age, religion, gender, gender identity, sexual orientation, nationality, disability, ethnic or social background. We are committed to equal opportunities and inclusion.
For data protection reasons, we only accept applications via our application portal. The contact details provided below are intended solely for inquiries.
If you have questions, please contact:
For further information, please visit our website www.immunoprecept.de. Enquiries about the positions and perspectives should be addressed to immunoprecept-career@charite.de and Prof. Dr. Johannes Vogel (Johannes.Vogel@mfn.berlin).
7474
Weitere Aktionen
Abonnieren Sie unsere Job-Mail!
Universität Wien
Universität Wien
Universität Wien
